课题基金 / 基金详情

Exploration of Target Molecules Related to Pathogenesis and Development of Therapy for Sporadic ALS

Exploration of Target Molecules Related to Pathogenesis and Development of Therapy for Sporadic ALS
散发性ALS发病机制相关靶分子探索及治疗进展
批准号:
17390253
负责人:
TANAKA Fumiaki
金额:
$9.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

TANAKA Fumiaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
For the elucidation of pathogenesis and therapy development of sporadic ALS, it might be an effective strategy to create disease models by reproduction of early gene expression changes observed in the patients' tissues. Gene expression analysis was performed in ALS and control spinal motor neurons isolated by laser microdissection technique. As a result, we have identified 196 genes in total that revealed motor neuron-specific expression changes in ALS. We have further analyzed expression dynamics of these genes including dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C in relation to pathological markers for motor neuron degeneration (i.e., cytoplasmic accumulation of phosphorylated neurofilament-H (pNF-H) and ubiquitylated protein) and the numbers of residual motor neurons. Through this analysis, we have identified dynactin 1 as one of the genes of which expression changes occurred in the early phase of neurodegeneration in sporadic ALS. We next tried to reproduce gene expression change of dynactin 1 in cultured cell using siRNA technique and analyzed the effect of gene knockdown employing various assay systems.Neuronal cell death was induced by dynactin 1 knockdown and the role of autophagy in this cell death pathway was investigated. As a result, we observed that autophagosome formation was accelerated due to impairment of the autophagosome-lysosome fusion caused by the inefficient function of dynactin 1.Moreover, accumulation of polyubiquitinated protein was suggested in the cells with down-regulated dynactin 1. We suppose that down-regulation of dynactin 1 might lead to accumulation of aberrant proteins unprocessed by autophagic pathway due to its impairment and cause neuronal cell death.Impairment of autophagy was observed also in spinal motor neurons of ALS patients, suggesting that dynactin 1 knockdown cell system might be a good disease model that reflects some part of important pathogenesis of sporadic ALS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1523/jneurosci.3032-06.2006
发表时间: 2006-11-22
期刊: JOURNAL OF NEUROSCIENCE
影响因子: 5.3
作者: [Katsuno, Masahisa, Adachi, Hiroaki, Sobue, Gen]
通讯作者: Sobue, Gen
DOI: 10.1002/ana.20379
发表时间: 2005-02-01
期刊: ANNALS OF NEUROLOGY
影响因子: 11.2
作者: [Jiang, YM, Yamamoto, M, Sobue, G]
通讯作者: Sobue, G
DOI: 10.1093/brain/awl096
发表时间: 2006-06-01
期刊: BRAIN
影响因子: 14.5
作者: [Atsuta, Naoki, Watanabe, Hirohisa, Sobue, Gen]
通讯作者: Sobue, Gen
Gene expression profiling toward understanding of ALS pathogenesis
基因表达谱分析有助于了解 ALS 发病机制
DOI: --
发表时间: 2006
期刊: Ann N Y Acad Sci 1086
影响因子: --
作者: [Tanaka F, Niwa J, Ishigaki S, Katsuno M, Waza M, Yamamoto M, Doyu M, Sobue G]
通讯作者: Sobue G
11
    Development of ALS therapy targeting LOTUS, a functional molecule for neuronal regeneration
    • 批准号:
      18K07532
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      TANAKA Fumiaki
    • 依托单位:
    Analysis of RNA binding proteins in polyglutamine disease
    • 批准号:
      26670445
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      TANAKA Fumiaki
    • 依托单位:
    Integrated research of polyglutamine disease and ALS/FTLD by analysis of UBQLN2
    • 批准号:
      25293207
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2013
    • 负责人:
      TANAKA Fumiaki
    • 依托单位:
    Elucidation of pathogenesis and therapy development of sporadic ALS by disease model
    海外基金